Zvitambo Institute For Maternal And Child Health Research

Zvitambo Institute For Maternal And Child Health Research is a non-profit international organization registered in the System for Award Management (SAM) with a focus on maternal and child health research. Located in Zimbabwe, the organization specializes in conducting scientific research related to child health, HIV exposure, and developmental outcomes. The institute provides research services to federal agencies, particularly in the realm of public health and medical research, with a demonstrated commitment to understanding complex health challenges affecting children and mothers in rural settings.

Through federal contract awards, Zvitambo Institute has secured at least one notable contract with the National Human Genome Research Institute (NHGRI), a civilian federal agency. The most recent contract, awarded on August 30, 2024, is a firm fixed-price purchase order valued at $86,324.77, focusing on research related to maternal and child health in Zimbabwe. The contract, which does not have a specific set-aside designation, has an ultimate completion date of August 30, 2027. This indicates the institute's capability to execute targeted research projects for federal agencies, demonstrating expertise in conducting specialized health-related investigations in international contexts.

Regarding federal grant awards, Zvitambo Institute has received significant funding from the National Institute of Child Health and Human Development for research on HIV-exposed uninfected children. Specifically, two grants (R61HD103101 and R33HD103101) were awarded on August 21, 2020, with completion dates in 2025 and 2026, respectively. These grants focus on a comprehensive study of clinical outcomes for HIV-exposed uninfected children in rural Zimbabwe, involving a cohort of 900 children. The research aims to understand health disparities, growth patterns, physical and cognitive functions of HIV-exposed and HIV-unexposed children. The grants involve detailed longitudinal assessments, including monthly health surveillance, baseline and annual evaluations of growth, physical and cognitive function, and in-depth phenotyping of a subgroup of 300 children to provide insights into the long-term health impacts of early-life exposures.